4.6 Article

Vascular Endothelial Growth Factors A and C are Induced in the SVZ Following Neonatal Hypoxia-Ischemia and Exert Different Effects on Neonatal Glial Progenitors

期刊

TRANSLATIONAL STROKE RESEARCH
卷 4, 期 2, 页码 158-170

出版社

SPRINGER
DOI: 10.1007/s12975-012-0213-6

关键词

Neonatal hypoxia-ischemia; Subventricular zone; Glial progenitor; Oligodendrocyte; Astrocyte; Vascular endothelial growth factor; Cytokine

资金

  1. National Institute of Neurological Disorders and Stroke and National Institute of Child Health and Development [F31NS062629, F31NS076269]
  2. Leducq Foundation [R01HD052064]

向作者/读者索取更多资源

Episodes of neonatal hypoxia-ischemia (H-I) are strongly associated with cerebral palsy and a wide spectrum of other neurological deficits in children. Two key processes required to repair damaged organs are to amplify the number of precursors capable of regenerating damaged cells and to direct their differentiation towards the cell types that need to be replaced. Since hypoxia induces vascular endothelial growth factor (VEGF) production, it is logical to predict that VEGFs are key mediators of tissue repair after H-I injury. The goal of this study was to test the hypothesis that certain VEGF isoforms increase during recovery from neonatal H-I and that they would differentially affect the proliferation and differentiation of subventricular zone (SVZ) progenitors. During the acute recovery period from H-I, both VEGF-A and VEGF-C were transiently induced in the SVZ, which correlated with an increase in SVZ blood vessel diameter. These growth factors were produced by glial progenitors, astrocytes, and to a lesser extent, microglia. VEGF-A promoted the production of astrocytes from SVZ glial progenitors, while VEGF-C stimulated the proliferation of both early and late oligodendrocyte progenitor cells (OPCs), which was abolished by blocking VEGFR-3. Altogether, these results provide new insights into the signals that coordinate the reactive responses of the progenitors in the SVZ to neonatal H-I. Our studies further suggest that therapeutics that can extend VEGF-C production and/or agonists that stimulate VEGFR-3 will promote OPC development to enhance myelination after perinatal brain injury.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据